C
Carlos Zarate Jr.
Chief of Experimental Therapeutics at NIMH
Key Impact
A pioneer whose work demonstrated the rapid antidepressant and anti-suicidal effects of ketamine.
Background & Research
Dr. Carlos Zarate Jr. is an NIH Distinguished Investigator and a leading authority on treatment-resistant mood disorders. His landmark research at the NIMH has fundamentally shifted the psychiatric landscape by proving the efficacy of ketamine as a rapid-acting therapeutic for depression and suicidality. He continues to explore the neurobiological pathways of mood disorders using advanced imaging and genomic techniques.
Focus Areas
KetamineMood DisordersSuicide PreventionNeuropsychopharmacology